Aravive, Inc. - stock earnings
Stock symbol ARAV is outdated, potentially delisted? Maybe it is available on other exchange?
ARAV Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2022Q4 | -29.1 million USD | 1.5 million USD |
| 2022Q3 | -15.7 million USD | 5.0 million USD |
| 2022Q2 | -18.5 million USD | 1.6 million USD |
| 2022Q1 | -13.1 million USD | 1.1 million USD |
| 2021Q4 | -13.0 million USD | 985000 USD |
| 2021Q3 | -11.1 million USD | 2.4 million USD |
| 2021Q2 | -7.1 million USD | 3.8 million USD |
| 2021Q1 | -8.0 million USD | 256000 USD |
| 2020Q4 | -4.0 million USD | 5.7 million USD |
| 2020Q3 | -10.7 million USD | ? USD |
ARAV Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2022 | -76.3 million USD | 9.1 million USD |
| 2021 | -39.2 million USD | 7.4 million USD |
| 2020 | -30.5 million USD | 5.7 million USD |
| 2019 | -18.2 million USD | 4.8 million USD |
| 2018 | -76.3 million USD | 1.4 million USD |
| 2017 | -85.0 million USD | 40.0 million USD |
ARAV
Price: $0.04
52 week price:
Earnings Per Share: -0.76 USD
P/E Ratio: -0.05
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Volume: 319789
Market Capitalization: 2.9 million